Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Aptorum Group Announces Positive Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus

americanpharmaceuticalreviewMay 28, 2021

Tag: Aptorum , ALS-4 , Pre-IND

PharmaSources Customer Service